Study of SAR441236, a Tri-specific Broadly Neutralizing Antibody,

Recruiting

18 years - 99 years

All

Phase 1

84 participants needed

1 Location

Brief description of study

The purpose of this study is to test the safety of SAR441236, a study drug that has not been tested in humans before now. The study will also look at how long SAR441236 stays in the body after one dose and after four doses. It will also look at whether SAR441236 can reduce the level of HIV (the virus that causes AIDS).

Detailed description of study

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Medical Research, HIV
Age: 18 years - 99 years
Gender: All

Updated on 04 Aug 2024. Study ID: 844614

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Study of SAR441236, a Tri-specific Broadly Neutralizing Antibody, in Participants with HIV

Brief description of study

Detailed description of study

Eligibility of study

Find a site

Interested in the study